The Briefing: Skechers, TikTok, and Khaby Lame: Is Barrett Wissman Potentially Liable?
The LathamTECH Podcast — Trade Secrets: The New Litigation Battleground
Podcast: Williams Mullen's Trending Now - An IP Podcast - When AI Meets Art: Litigation and Settlement Trends Affecting Artists
The Briefing: Vetter v. Resnik: When Copyright Termination Goes Global
IP Goes Pop! S7 Ep 1- We’re #1! Intellectual Property Firsts
Why Won't the USPTO Register My Last Name? — No Infringement Intended Podcast
The Briefing: Kat Von D, Miles Davis, and the Possible Death of the Intrinsic Test?
2026 Trends to Watch: Regulation, Infrastructure and IP in Motion
'Desk Drawer Roundup': NIL Contract Fights, Eligibility Battles, and the CSC Participation Agreement — Highway to NIL Podcast
The Briefing: Part Two: CCPA’s New Rules on Risk Assessments and Cybersecurity Audits
The Briefing: Part One: CCPA’s New Rules on Automated Decision making Technology (ADMT)
We get AI for work™: New Efforts to Ensure a National AI Policy
The Briefing: Why Lady Gaga Beat a Trademark Injunction Over “Mayhem”
Beyond the Deals: Student-Athlete Identity, Development, and NIL With 42U's Stephen Bienko — Highway to NIL Podcast
The Privacy Insider Podcast Episode 22: The Data Privacy of the Dead & Critiquing the Digital Divine with Carl Öhman of Uppsala University
Why Does Everyone Say 'The Big Game' Instead of 'Super Bowl'? — No Infringement Intended Podcast
The Briefing: Top Gun Cleared for Takeoff: The Ninth Circuit Affirms Paramount’s Copyright Win
The Briefing: The 2026 Forecast: Resolving Some of the Entertainment Industry’s Open Legal Issues
The Briefing: 2025 IP Resolutions Start With a Review of IP Assets (Featured)
Wolf Greenfield Attorneys Review 2025 and Look Ahead to 2026
In a closely watched case regarding copyright protection for AI-created works, on March 2, 2026, the Supreme Court of the United States declined to grant review in Thaler v. Perlmutter (Case No. 25-449). In denying...more
A Florida appellate panel on Friday blocked a lower court's temporary injunction giving an extra year of eligibility for a college basketball player, ruling in a split opinion that the order's findings weren't sufficient to...more
In Fish & Richardson’s 2025 biologics and biosimilars review, we cover Food and Drug Administration (FDA) approvals, new biosimilar launches, Biologics Price Competition and Innovation Act (BPCIA) litigation and other...more
In Sanas.AI Inc. v. Krisp Technologies, Inc., Chief Judge Richard Seeborg of the U.S. District Court for the Northern District of California denied Krisp's Rule 12(c) motion challenging five Sanas patents on accent...more
Etanercept Challenged Claim Types in IPR and Litigation: Claims include those challenged in litigations and IPRs. Claims are counted in each litigation and IPR, so claims from the same patent challenged in multiple...more
In Dusome v. Canada (Attorney General), 2025 FC 1809, the Federal Court reviewed the Commissioner of Patents' decision refusing to grant Canadian Patent Application Number 2,701,028 on the basis that it was a “mere scientific...more
FDA recently published a new draft Guidance for Industry titled “New Clinical Investigation Exclusivity (3-Year Exclusivity) for Drug Products: Questions and Answers” (Mar. 2026) (the “Draft Guidance”). The Draft Guidance...more
Part one of this series highlighted the historic high that trade secret litigation hit in 2025 with more than 1,550 cases filed in courts across the United States and suggested proactive, common-sense steps that businesses...more
Fusion power can potentially provide the world with safe, clean, and renewable power. As recent advances in superconducting magnet fabrication and AI-enabled field optimization propel stellarators from academic endeavors...more
The University of Alabama in Huntsville (UAH) and aerospace company ASKA have agreed to explore collaboration on a drive-and-fly aircraft. The proposed joint development exemplifies the need for careful consideration of...more
A case currently before the Trademark Trial and Appeal Board (“TTAB”) has the potential to significantly widen the scope of trademark dilution protection by allowing companies to point to past success as evidence of current...more
GENUINE ENABLING TECHNOLOGY LLC v. SONY GROUP CORPORATION - Before Dyk, Taranto, and Chen. Appeal from the United States District Court for the District of Delaware. The Federal Circuit affirmed summary judgment of...more
WILLIS ELECTRIC CO., LTD. v. POLYGROUP LTD. (MACAO COMMERCIAL OFFSHORE) - Before Moore, Stark, and Oetken (sitting by designation). Appeal from the United States District Court for the District of Minnesota. Neither the fact...more
Artificial Intelligence (AI) serves as a double-edged sword, presenting economic risks and the potential to disrupt and harm various industries, while simultaneously enabling significant innovation and growth across many...more
Our Case of the Week touches on two claim construction issues – a post-jury-verdict “clarification” of a claim term by a judge, who overturned a jury verdict, and a determination whether the term “diverter” was subject to...more
The Chinese National Intellectual Property Administration (CNIPA) has stopped copying local Chinese trademark agents on notifications for international trademarks designating China through the Madrid System....more
Tocilizumab Challenged Claim Types in IPRs: Claims are counted in each IPR, so claims from the same patent challenged in multiple IPRs are counted more than once. Within each IPR, claims are counted only once, whether they...more
Denosumab Challenged Claim Types in Litigation: Claims are counted in each litigation, so claims from the same patent challenged in multiple litigations are counted more than once. Within each litigation a claim is counted...more
The U.S. Supreme Court will decide what constitutes “induced infringement” where the generic manufacturer makes statements outside approved labeling that carves out a patented use....more
For a long time, game patents felt like a relic from an earlier era. Many developers may have assumed they were either expired, irrelevant, or unlikely to be enforced in a meaningful way. That view is starting to change....more
Pegfilgrastim Challenged Claim Types in IPR and Litigation: Claims include those challenged in litigations and IPRs. Claims are counted in each litigation and IPR, so claims from the same patent challenged in multiple...more
Disclose Theories at the Outset- A recent decision by U.S. Magistrate Judge Jessica S. Allen underscores the importance of developing and disclosing theories relating to patent invalidity and infringement at the outset of...more
The texts of the new European Union (“EU”) General Pharmaceutical Legislation, which is comprised of a Directive to replace Directive 2001/83 and a Regulation to replace Regulation 726/2004, have been published. These texts...more
Social media – previously just a platform for personal connection and conversation – is now a powerful marketing and advertising channel, with brands increasingly relying on influencer partnerships, social media giveaways,...more
In today’s interconnected business world, digital transformation touches every corner of an enterprise. Those who embrace it will flourish, and those who don’t will be left behind. Womble Bond Dickinson invites you to join...more